Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b4108625afe54f96efc893c33911570 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H23-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
filingDate |
1995-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b68d03f5eee182edfeb08c0c0e0c562 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0bddf8f36b94e4f5011272e028ab58b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c9796f3c7480c6234270c6d07a53245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9748b56d313bcc31a7fef83151336e91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dd423b36d033a0432d1bce65cf04e03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a771bbfdead408cb9e1d0e15491327db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e8945e33c90da5c0294b10df485ebee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0019da3c57a61795f8895703e02075aa |
publicationDate |
1996-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9602274-A1 |
titleOfInvention |
Conjugates made of metal complexes and oligonucleotides |
abstract |
This invention relates to chemically modified oligonucleotide conjugates that contain a complexing agent or complex that is bound by a connecting component to the oligonucleotides. In this case, the oligonucleotides are modified in a way that prevents or at least significantly inhibits the degradation by naturally occurring nucleases. The oligonucleotide radical can bond specifically and with high bonding affinity to target structures and can thus produce a specific therapeutic or diagnostic effect by the bound complexing agent or complex. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1112279-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9800435-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9800435-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1112279-A1 |
priorityDate |
1994-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |